Earum Pharmaceuticals Limited
Earum Pharmaceuticals Limited (EARUM.BO) Stock Competitors & Peer Comparison
See (EARUM.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EARUM.BO | ₹1.75 | -9.33% | 0 | N/A | N/A | N/A |
| POLYMED.BO | ₹1,336.30 | +4.31% | 135.4B | 39.21 | ₹34.08 | +0.26% |
| POLYMED.NS | ₹1,334.20 | +3.97% | 135.2B | 39.09 | ₹34.13 | +0.26% |
| AGARWALEYE.NS | ₹417.00 | -0.60% | 132.1B | 104.51 | ₹3.99 | N/A |
| SHAILY.NS | ₹2,083.30 | -0.52% | 95.7B | 60.58 | ₹34.39 | +0.10% |
| LAXMIDENTL.NS | ₹180.31 | +1.60% | 9.9B | 42.83 | ₹4.21 | N/A |
| TARSONS.BO | ₹182.40 | +1.33% | 9.7B | 47.62 | ₹3.83 | N/A |
| TARSONS.NS | ₹181.63 | +0.97% | 9.7B | 47.42 | ₹3.83 | N/A |
Stock Comparison
EARUM.BO vs POLYMED.BO Comparison April 2026
EARUM.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EARUM.BO stands at 0. In comparison, POLYMED.BO has a market cap of 135.4B. Regarding current trading prices, EARUM.BO is priced at ₹1.75, while POLYMED.BO trades at ₹1,336.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EARUM.BO currently has a P/E ratio of N/A, whereas POLYMED.BO's P/E ratio is 39.21. In terms of profitability, EARUM.BO's ROE is +0.11%, compared to POLYMED.BO's ROE of +0.13%. Regarding short-term risk, EARUM.BO is less volatile compared to POLYMED.BO. This indicates potentially lower risk in terms of short-term price fluctuations for EARUM.BO.Check POLYMED.BO's competition here